Planned 10,000-share Rule 144 sale by issuer (FFBC) disclosed

Rhea-AI Filing Summary

A security holder of FFBC has filed a notice of proposed sale of 10,000 shares of common stock under Rule 144. The shares are to be sold through Charles Schwab Corp, with an aggregate market value of $302,600, and an approximate sale date of 02/13/2026 on the Nasdaq market.

The filing lists how these shares were originally acquired over time, including open market purchases, a merger with the issuer, and equity compensation grants. By signing, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp 3000 Schwab Way Westlake TX 76262	10000	302600.00	98529694	02/13/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2007	Open Market Purchase	Open Market			28	07/30/2007	Cash
Common	02/12/2009	Open Market Purchase	Open Market			49	02/12/2009	Cash
Common	02/13/2009	Open Market Purchase	Open Market			28	02/13/2009	Cash
Common	04/01/2018	Merger	Issuer			8637	04/01/2018	Merger
Common	04/02/2020	Equity Compensation	Issuer			670	04/02/2020	Equity Compensation
Common	02/12/2022	Equity Compensation	Issuer			18	02/12/2022	Equity Compensation
Common	02/12/2023	Equity Compensation	Issuer			571	02/12/2023	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the FFBC Rule 144 filing disclose about share sales?

The filing discloses a planned sale of 10,000 FFBC common shares under Rule 144. The shares have an aggregate market value of $302,600 and are expected to be sold on 02/13/2026 through Charles Schwab Corp on the Nasdaq market.

How many FFBC shares are planned to be sold and at what value?

The filing reports a planned sale of 10,000 common shares of FFBC. These shares have an aggregate market value of $302,600, based on the market price at the time of the notice, and are slated for sale through Charles Schwab Corp.

When is the planned sale date for the FFBC common stock under Rule 144?

The notice indicates an approximate sale date of 02/13/2026 for the 10,000 FFBC common shares. This timing is part of the Rule 144 process and reflects when the security holder expects to execute the planned Nasdaq sale through Charles Schwab Corp.

On which exchange will the 10,000 FFBC shares be sold according to the filing?

The Rule 144 notice states that the 10,000 FFBC common shares are expected to be sold on the Nasdaq exchange. The planned sale uses Charles Schwab Corp as broker, with an aggregate market value noted at $302,600 in the filing.

How were the FFBC shares in the Rule 144 notice originally acquired?

The filing shows the shares were acquired through several methods: open market purchases in 2007 and 2009, a merger with the issuer in 2018, and multiple equity compensation grants from 2020 to 2023, each with specific acquisition dates and share amounts listed.

What representation does the seller of FFBC shares make in the Rule 144 notice?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements and the form’s criminal liability warning.